EVAX

Evaxion A/S (EVAX)

About Evaxion A/S (EVAX)

Evaxion AS engages in the discovery and development of immunotherapies for cancer and infectious diseases. Its technologies include the immuno-oncology platform PIONEER, the bacterial disease platform EDEN, the viral disease platform RAVEN, and the proprietary AI platform technology ObsERV. The company was founded by Niels Iversen Møller and Andreas Holm Mattsson on August 11, 2008 and is headquartered in Hoersholm, Denmark.

Details

Daily high

$5.86

Daily low

$5.17

Price at open

$5.45

52 Week High

$12.15

52 Week Low

$1.20

Market cap

34.5M

Dividend yield

0.00%

Volume

75,705

Avg. volume

255,346

P/E ratio

-.92

Evaxion A/S News